Latest News

• share
• favorite_border

• share
• favorite_border

A research study conducted by Amanda Fallin in the University of Kentucky College of Nursing recently exposed how tobacco companies rallied around the tobacco-growing states during the anti-tobacco movement. As a result, today the five top tobacco growing states continue to lead the nation in smoking rates and lung disease.

• share
• favorite_border

Could a fatalistic attitude toward cervical cancer serve as a barrier to prevention of the disease? A recent study conducted by University of Kentucky researchers in the Rural Cancer Prevention Center suggests a link between fatalistic beliefs and completion of the human papillomavirus (HPV) vaccine series among a sample of young Appalachian Kentucky women.

• share
• favorite_border

Researchers at the University of Kentucky's Sanders-Brown Center on Aging have completed a study that revealed differences in the way brain inflammation -- considered a key component of AD-- is expressed in different subsets of patients, in particular people with Down syndrome (DS) and AD.

• share
• favorite_border

• share
• favorite_border

A University of Kentucky marketing professor is co-author of a just-published study that suggests the thrill a person feels at seeing one particular item while shopping often carries over to unrelated items.

• share
• favorite_border

Artificial blood for mosquitoes is being developed by Stephen Dobson, a UK professor of medical and veterinary entomology. The approach has the potential to sterilize and eventually eliminate mosquito populations that transmit diseases like malaria.

• share
• favorite_border

CGRP monoclonal antibodies appear to significantly reduce the frequency of migraine in human clinical trials, potentially changing the landscape for migraine treatment. Headache specialist Sid Kapoor, MD, discusses the enormous potential -- and pitfalls-- facing the drug class' road to FDA approval.

• share
• favorite_border

A new study co-led by Hsin-Hsiung Tai, professor of pharmaceutical sciences at the University of Kentucky, suggests that a key prostaglandin (PG) metabolic enzyme shows promise as a drug target to help tissue regeneration and repair, particularly after bone marrow transplantation and tissue injuries.

• share
• favorite_border

In clinical trials, a new drug class known as PCSK9 Inhibitors reduced bad cholesterol markedly and is expected to be approved by the FDA this summer. An expert in lipid management discusses some of the barriers to its use.

• share
• favorite_border

The quest to digitally uncover writings inside a 2,000-year old scroll continues with a new computer software tool built at the University of Kentucky, the "Volume Cartographer," and a trip to Paris, France with four UK students.

• share
• favorite_border

Early diagnosis and intervention is key to assuring the best possible health outcome. In 2-week old Bransen Robert's case, a new program at the University of Kentucky called The Blue Angels made this early intervention possible.

• share
• favorite_border

Brooke Estep has Down Syndrome, but it doesn't stop her from living fully, including participating in research at the Sanders-Brown Center on Aging that hopes to unlock the mysteries of Alzheimer's and other age-related dementias

• share
• favorite_border

What happens when a community is faced with the disturbing possibility that their children could be exposed to harmful chemicals every day? They call in experts like Kelly Pennell, UK professor of civil engineering, whose research can shed light on a common, but potentially dangerous issue.

• share
• favorite_border

University of Kentucky Department of Chemistry Assistant Professor Jason DeRouchey has received a prestigious five-year, $691,000 Faculty Early Career Development (CAREER) Award from the National Science Foundation.

• share
• favorite_border

The University of Kentucky Markey Cancer Center recently launched a new iPhone app featuring a searchable database of the open clinical trials at Markey. The app gives Markey patients and their treatment teams an easier way of identifying the clinical trials currently offered that might be beneficial for the patient’s treatment plans.

• share
• favorite_border

Researchers in the University of Kentucky College of Nursing are using an electronic salt spoon to help families transition to low-sodium diets.

• share
• favorite_border

Since the 1960s, the number six has been commonly used to describe how many people are impacted by each suicide. Julie Cerel, associate professor in the University of Kentucky College of Social Work, says that's just not true, and her research has produced a startling statistic.

• share
• favorite_border

Researchers at the University of Kentucky’s Sanders-Brown Center on Aging have been attempting to understand the cascade of events following mild head injury that may lead to an increased risk for developing a progressive degenerative brain disease, and their new study, which was published in the current issue of the Journal of Neuroscience, shows initial promise for a treatment that might interrupt the process that links the two conditions.

• share
• favorite_border

Marion Cox was experiencing the expected decline in the potency of his medications for Parkinson's disease when his doctor offered him a spot in a clinical trial for a new drug delivery system. Now Marion has returned to farming his 800 acres -- including operating heavy equipment -- with a small pump in a pouch under his shirt that delivers precision doses of levidopa to control his PD symptoms with minimal side effects.

• share
• favorite_border

Medical residents are testing the effectiveness of a text message alert system to improve patient compliance with the recommended vaccination schedule.

• share
• favorite_border

As the anniversary of the most fatal landslide in the history of the continental United States approaches, we are reminded of the importance of evaluating geologic hazards and communicating that information to communities that may be at risk, including Kentucky, where landslides were reported in in Muhlenburg and Caldwell counties this month.

• share
• favorite_border

Citing a critical need for a forum dedicated solely to mechanical assisted circulation, Dr. Maya Guglin of the Gill Heart Institute at the University of Kentucky has launched The VAD Journal.

• share
• favorite_border

This video features offers an inside look at the U.S. Lab where Brent Seales develops digital imaging software to unlock the mysteries of these ancient European scrolls.

• share
• favorite_border

• share
• favorite_border

Scientists have been searching for missing oil from the Deepwater Horizon oil spill, also called the BP oil spill, since 2010, and now Kevin Yeager, professor in the UK Department of Earth and Environmental Sciences, and his research colleagues may have solved the mystery.

• share
• favorite_border

University of Kentucky neonatologist Henrietta Bada recently published a pilot study examining the effectiveness of a non-opiate drug clonidine to treat neonatal abstinence syndrome.

• share
• favorite_border

Maya Guglin, MD, PhD, Director of Mechanical Assisted Circulation at the University of Kentucky's Gill Heart Institute, has launched The VAD Journal, a publication focused exclusively on mechanical assisted circulation.

• share
• favorite_border

Researchers at the University of Kentucky have unlocked the metabolic function of the essential enzyme laforin, which opens new pathways to treating the deadly Lafora's Disease.

• share
• favorite_border

A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer.

• share
• favorite_border

University of Kentucky Department of Computer Science's Brent Seales is on his way to making history, and uncovering it, with revolutionary software and 2,000-year old Herculaneum scrolls.

• share
• favorite_border

A new UK program is more than just a win-win situation. Watch how college students are not only reaching out to help those in need but also working to solve the problem of food waste and building community all at once.

• share
• favorite_border

University of Kentucky researchers have exposed new information about the combined cognitive effects of mild traumatic brain injury and posttraumatic stress disorder in war veterans.

• share
• favorite_border

This video feature tells the story of a new initiative helping to battle hunger on the University of Kentucky campus. The program isn't just helping those in need, but offering valuable educational experience to students interested in human nutrition & food insecurity issues.

• share
• favorite_border

A group of physiologists led by University of Kentucky's Tim McClintock, PhD, have identified the receptors activated by two odors using a new method that tracks responses to smells in live mice.

• share
• favorite_border

A recent study by Allison Scott, assistant professor in the UK College of Communication and Information, examines how the quality of communication among family members and care givers impacts end-of-life decisions. Scott says family communication holds a great deal of potential for improving end-of-life health care.

• share
• favorite_border

A landmark study published today in the journal Science by an international group of scientists, led by the laboratory of Dr. Jayakrishna Ambati, professor and vice chair of the Department of Ophthalmology & Visual Sciences at the University of Kentucky, reports that HIV/AIDS drugs that have been used for the last 30 years could be repurposed to treat age-related macular degeneration (AMD), as well as other inflammatory disorders, because of a previously undiscovered intrinsic and inflammatory activity those drugs possess.

• share
• favorite_border

A multi-institutional study has defined and established criteria for a new neurological disease closely resembling Alzheimer’s disease called primary age-related tauopathy (PART). Patients with PART develop cognitive impairment that can be indistinguishable from Alzheimer’s disease, but they lack amyloid plaques. Awareness of this neurological disease will help doctors diagnose and develop more effective treatments for patients with different types of memory impairment.

• share
• favorite_border

• share
• favorite_border

University of Kentucky professor Dr. Greg Davis, a forensic pathologist, has investigated four of 17 cases of El Salvadoran women who were convicted of murdering their babies. His report submitted to the government disproves the outdated float test used to convict these women.

• share
• favorite_border

The National Institute of Mental Health has awarded a grant to University of Kentucky College of Education Professor Lisa Ruble and a team of co-investigators to find ways to help reduce or eliminate the disconnect from needed services that often occurs when students with autism complete school.

• share
• favorite_border

Dr. Jayakrishna Ambati, internationally renowned ophthalmology researcher and professor and vice chair of the Department of Ophthalmology and Visual Sciences at the University of Kentucky, will discuss and answer questions online regarding his laboratory’s discovery and study of a previously unknown form of DNA that is outside the human genome and that could have a profound impact on biology and medicine and in study of macular degeneration.

• share
• favorite_border

New research by scientists at the University of Kentucky's Sanders-Brown Center on Aging suggests that people who notice their memory is slipping may be on to something.

• share
• favorite_border

Two independent groups of researchers led by Sidney (Wally) Whiteheart, PhD, of the University of Kentucky, and Charles Lowenstein, MD, of the University of Rochester, have published important studies exploring the role that a gene called STXBP5 plays in the development of cardiovascular disease.

• share
• favorite_border

A new study by University of Kentucky researchers has identified a novel molecule named Arylquin 1 as a potent inducer of Par-4 secretion from normal cells. Par-4 is a protein that acts as a tumor suppressor, killing cancer cells while leaving normal cells unharmed.

• share
• favorite_border

A team of investigators from the University of Kentucky has made a thought-provoking discovery about a type of cholesterol previously believed to be a "bad guy" in the development of heart disease and other conditions.

• share
• favorite_border

The explosion of the Internet and social media has literally put the world at our fingertips, revolutionizing the way people connect and share information. However, for all the positives social media provides, it can also open the door to deception, potentially wreaking havoc on people's lives both personally and professionally.

• share
• favorite_border

A new web-based program developed by University of Kentucky Markey Cancer Center researchers will provide a simple, free way for healthcare providers to determine which brain tumor cases require testing for a genetic mutation.

• share
• favorite_border

The sounds of a 7,000-year-old language now echo through the halls of the University of Kentucky. Professors and students work together to reconstruct a spoken version of PIE (Proto-Indo-European).

• share
• favorite_border

From the first day of their lives, most boys and girls are treated differently. Those differences begin with a pink versus blue nursery, clothes with laces rather than ribbons, sports equipment or dance lessons, and on and on right through to “manly” careers versus “feminine” jobs.